Compare ABVX & PNFP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ABVX | PNFP |
|---|---|---|
| Founded | 2013 | 2000 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | | Major Banks |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2B | 7.8B |
| IPO Year | N/A | N/A |
| Metric | ABVX | PNFP |
|---|---|---|
| Price | $114.30 | $94.29 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 15 |
| Target Price | ★ $130.09 | $111.79 |
| AVG Volume (30 Days) | 1.8M | ★ 2.2M |
| Earning Date | 08-11-2025 | 01-21-2026 |
| Dividend Yield | N/A | ★ 2.10% |
| EPS Growth | N/A | ★ 35.40 |
| EPS | N/A | ★ 8.07 |
| Revenue | $6,231,374.00 | ★ $1,947,606,000.00 |
| Revenue This Year | $6.80 | $160.52 |
| Revenue Next Year | N/A | $8.18 |
| P/E Ratio | ★ N/A | $11.81 |
| Revenue Growth | N/A | ★ 20.51 |
| 52 Week Low | $4.77 | $81.57 |
| 52 Week High | $148.83 | $127.85 |
| Indicator | ABVX | PNFP |
|---|---|---|
| Relative Strength Index (RSI) | 42.99 | 41.03 |
| Support Level | $113.64 | $94.30 |
| Resistance Level | $125.00 | $107.00 |
| Average True Range (ATR) | 7.79 | 3.34 |
| MACD | -0.80 | -0.49 |
| Stochastic Oscillator | 26.16 | 0.48 |
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.
Pinnacle Financial Partners Inc is a financial holding company. The company operates through its wholly-owned subsidiary, Pinnacle Bank. The bank provides a full range of lending products, including commercial, real estate, and consumer loans to individuals and small to medium-sized businesses. It operates as a community bank mainly in the urban markets of Nashville, Knoxville, Memphis, and Chattanooga, Tennessee, as well as surrounding counties. It relies heavily on mergers and acquisitions. A majority of its loan portfolio is in commercial loans, mainly real estate, as well as industrial loans. The bank generates a majority of its net revenue through net interest income.